Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Viral Hepatitis|October 21, 2009
The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomesJ Turner, L Bansi, R Gilson, et al.HIV Medicine|November 9, 2010
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late startersL Waters, M Fisher, J Anderson, et al.Pharmacoeconomics|May 27, 1999
The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on CostsE J Beck, K Tolley, A Power, et al.HIV Medicine|November 21, 2008
The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapyC A Sabin, C J Smith, V Delpech, et al.HIV Medicine|February 12, 2010
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populationsL Bansi, C Sabin, V Delpech, et al.The Journal of Experimental Medicine|July 6, 2000
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic functionV Appay, D F Nixon, S M Donahoe, et al.HIV Medicine|May 17, 2011
Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) studyR A Hughes, J A C Sterne, J Walsh, et al.Neurology|February 23, 2011
Antiretroviral therapy CNS penetration and HIV-1-associated CNS diseaseL Garvey, A Winston, J Walsh, et al.Pageof 4